Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GDA-201 |
Trade Name | |
Synonyms | |
Drug Descriptions |
GDA-201 is composed of ex vivo activated donor natural killer cells, which may have persistent anti-tumor activity (Blood (2019) 134 (Supplement_1): 777). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Elotuzumab + GDA-201 | Elotuzumab GDA-201 | 0 | 0 |
GDA-201 | GDA-201 | 0 | 1 |
GDA-201 + Rituximab | GDA-201 Rituximab | 0 | 0 |